Clinical trial · Observational
Determining Clinical Trial Experiences of Lung Cancer Patients
An Observational Study to Determine Experience Patterns in Participants of Lung Cancer Clinical Trials
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will admit a wide range of data on the clinical trial experience of lung cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future lung cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Number of lung cancer patients who decide to enroll in a clinical trial
- timeFrame
- 3 months
- measure
- Rate of patients who remain in a lung cancer clinical trial to trial completion
- timeFrame
- 12 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient has been diagnosed with lung cancer * Patient has self-identified as planning to enroll in an observational clinical trial * Patient is a minimum of 18 years or older Exclusion Criteria: * Pregnant or nursing patients * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form
References
Publications (3)
- BACKGROUNDMenis J, Besse B, Lacombe D. Methodology of clinical trials in lung cancer. Chin Clin Oncol. 2015 Dec;4(4):44. doi: 10.3978/j.issn.2304-3865.2015.11.03. PMID 26730756
- BACKGROUNDSchulkes KJ, Nguyen C, van den Bos F, van Elden LJ, Hamaker ME. Selection of Patients in Ongoing Clinical Trials on Lung Cancer. Lung. 2016 Dec;194(6):967-974. doi: 10.1007/s00408-016-9943-7. Epub 2016 Sep 20. PMID 27650509
- BACKGROUNDSchulkes KJ, Nguyen C, van den Bos F, Hamaker ME, van Elden LJ. Patient-Centered Outcome Measures in Lung Cancer Trials. Lung. 2016 Aug;194(4):647-52. doi: 10.1007/s00408-016-9903-2. Epub 2016 Jun 10. PMID 27287676